Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Isr Med Assoc J ; 22(5): 299-302, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32378822

RESUMEN

BACKGROUND: Although indwelling catheters are increasingly used in modern medicine, they can be a source of microbial contamination and hard-to-treat biofilms, which jeopardize patient lives. At times 70% ethanol is used as a catheter-lock solution due to its bactericidal properties. However, high concentrations of ethanol can result in adverse effects and in malfunction of the catheters. OBJECTIVES: To determine whether low concentrations of ethanol can prevent and treat biofilms of Pseudomonas aeruginosa. METHODS: Ethanol was tested at a concentration range of 0.625-80% against laboratory and clinical isolates of P. aeruginosa for various time periods (2-48 hours). The following parameters were evaluated following ethanol exposure: prevention of biofilm formation, reduction of biofilm metabolic activity, and inhibition of biofilm regrowth. RESULTS: Exposing P. aeruginosa to twofold ethanol gradients demonstrated a significant biofilm inhibition at concentrations as low as 2.5%. Treating pre-formed biofilms of P. aeruginosa with 20% ethanol for 4 hours caused a sharp decay in the metabolic activity of both the laboratory and clinical P. aeruginosa isolates. In addition, treating mature biofilms with 20% ethanol prevented the regrowth of bacteria encased within it. CONCLUSIONS: Low ethanol concentrations (2.5%) can prevent in vitro biofilm formation of P. aeruginosa. Treatment of previously formed biofilms can be achieved using 20% ethanol, thereby keeping the catheters intact and avoiding complications that can result from high ethanol concentrations.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Biopelículas/efectos de los fármacos , Etanol/administración & dosificación , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/fisiología , Antiinfecciosos Locales/farmacología , Infecciones Relacionadas con Catéteres/prevención & control , Etanol/farmacología , Humanos , Pruebas de Sensibilidad Microbiana , Infecciones por Pseudomonas/prevención & control
2.
Expert Rev Anti Infect Ther ; 12(5): 621-32, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24661314

RESUMEN

Acute infectious gastroenteritis continues to be a leading cause of morbidity and mortality in children below 5 years of age, with the majority of deaths concentrated in 35 'low income' countries. In these countries the under five years of age mortality rates reach 100 per 1000 live births, of which a significant proportion are associated with acute diarrhea. Rotavirus, cryptosporidium, Shigella spp and enterotoxigenic Escherichia coli are the main pathogens causing disease in these settings, although other bacteria and parasites can cause moderate to severe disease in different regions and situations. Treatment of children in these setting should be focused on appropriate rehydration, early hospitalization of severely malnourished children, zinc supplementation, and in specific situations, antimicrobials should be considered. The rationale for antimicrobial use should be based on the potential benefits based on published literature and the opportunity for use. This review provides a pathogen-specific update on the potential benefits of antimicrobials and suggests an empirical management approach for children suffering an acute watery or bloody diarrhea in a resource-limited region.


Asunto(s)
Antiinfecciosos/uso terapéutico , Criptosporidiosis/terapia , Diarrea/terapia , Disentería Bacilar/terapia , Infecciones por Escherichia coli/terapia , Infecciones por Rotavirus/terapia , Enfermedad Aguda , Preescolar , Criptosporidiosis/parasitología , Países en Desarrollo , Diarrea/microbiología , Diarrea/parasitología , Diarrea/virología , Manejo de la Enfermedad , Disentería Bacilar/microbiología , Infecciones por Escherichia coli/microbiología , Fluidoterapia , Hospitalización , Humanos , Áreas de Pobreza , Infecciones por Rotavirus/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA